MIPS Value Pathways (MVPs): What Healthcare Providers Need to Know Before 2028
Traditional MIPS reporting has often felt like a compliance exercise first and a care improvement program second. Clinicians select measures, track category rules, submit data, and wait to see how payment adjustments land. The process can be time-consuming, especially when the measures do not clearly match the care a practice actually provides.
That is the problem CMS is trying to address with MIPS Value Pathways, better known as MVPs. These newer reporting options are designed to organize MIPS around specialties, conditions, and episodes of care instead of a broad menu of disconnected measures.
CMS has signaled that traditional MIPS reporting is expected to be replaced by MVP reporting by 2029. That gives practices time to prepare, but not time to ignore it. The shift affects measure selection, technology, team workflows, and the way practices connect quality data to patient outcomes.
What MIPS MVPs are
MIPS stands for the Merit-based Incentive Payment System. It is part of the Quality Payment Program created under MACRA, and it affects many Medicare Part B clinicians. Under MIPS, eligible clinicians and groups report performance data that can affect future Medicare payment adjustments.
MVPs are a newer way to participate in MIPS. The full name is MIPS Value Pathways. Instead of choosing from a large set of measures across different performance categories, participants report within a more focused pathway.
An MVP usually centers on a clinical area, specialty, patient population, or care episode. For example, an MVP may group together measures that make sense for a specialty practice or for clinicians treating a common condition. The goal is to make reporting feel less random and more tied to the care delivered.
Traditional MIPS asks a broad question: “Which measures will this practice report?”
MVPs ask a more focused question: “Which connected set of measures best reflects this type of care?”
That difference matters. A practice that treats patients with a defined clinical need can work from a smaller, more relevant measure set. The reporting process still covers major MIPS categories, but the pathway gives the work a clearer frame.
MVPs generally include:
Quality measures tied to the pathway
Cost measures where applicable
Improvement activities related to the care area
Promoting Interoperability requirements for eligible clinicians
A population health measure selected or calculated through CMS processes
Specific MVP requirements can change from year to year. CMS updates available pathways, measure lists, and reporting rules through its annual rulemaking process. Practices should treat MVP planning as an ongoing task, not a one-time conversion.
How MVPs differ from the current MIPS framework
The current MIPS framework gives clinicians a wide menu of measures. That flexibility can be useful, but it also creates confusion. Practices may choose measures because they are easiest to report, not because they best describe care quality.
MVPs narrow the choices. They group related measures so that reporting reflects a more complete picture of a clinical area.
Traditional MIPS | MIPS MVPs |
Broad measure selection across the full MIPS program | Focused measure sets organized by pathway |
Practices choose measures that may not relate to each other | Measures are designed to connect around a specialty, condition, or care episode |
Reporting can feel separate from care improvement | Reporting is meant to align more closely with the patient journey |
Harder to compare similar clinicians when everyone reports different measures | Easier to compare performance within a more consistent pathway |
Practices may build workflows around compliance | Practices can build workflows around meaningful clinical priorities |
The four MIPS performance categories still matter. MVPs do not remove the core structure of MIPS. They reorganize it.
Quality becomes more connected to clinical context
In traditional MIPS, a practice may report quality measures from different areas because those measures are available in the electronic health record or easy to submit. That may help with compliance, but it may not tell a clear story about care.
In an MVP, quality measures sit inside a pathway. This encourages practices to track outcomes and processes that relate to a real clinical focus.
For example, a primary care pathway may emphasize preventive care, chronic disease management, and patient safety. A specialty pathway may focus on condition-specific results, follow-up, complications, or functional outcomes. The exact measures vary, but the principle is the same: quality reporting should match the kind of care being delivered.
Cost measures become harder to ignore
Cost has always been part of MIPS, but many clinicians have struggled to understand how cost performance connects to everyday decisions. MVPs aim to make that connection clearer by tying cost measures to the same clinical theme as the pathway.
This does not mean clinicians control every factor that drives cost. Patient complexity, access barriers, medication costs, and social needs all affect spending. Still, a more focused pathway can help practices see where care coordination, follow-up, avoidable utilization, and referral patterns may influence results.
Improvement activities should feel less disconnected
Improvement activities in traditional MIPS can sometimes feel like checkboxes. MVPs are meant to make those activities more relevant to the pathway.
A practice focused on chronic care management might select improvement work tied to care plans, patient engagement, medication reconciliation, or care coordination. A specialty group might focus on surgical safety, shared decision-making, or post-procedure follow-up.
The better the fit, the easier it is to turn reporting into daily practice change.
Why CMS is moving toward MVPs
The move toward MVPs reflects a larger goal in healthcare payment policy: measuring value in a way that is more consistent, comparable, and meaningful.
Traditional MIPS has faced criticism for being too broad. When clinicians can report very different measures, it becomes difficult to compare performance across similar practices. A large menu can also reward reporting strategy more than care improvement.
MVPs try to solve that by creating a shared structure. If similar clinicians report through the same pathway, CMS and practices can better understand performance trends. Patients and payers may also get a clearer picture of care quality, though public reporting details can vary.
The transition also supports a gradual move toward more advanced value-based care models. MVPs can serve as a bridge between traditional fee-for-service reporting and more coordinated models that focus on outcomes, cost, equity, and patient experience.
The biggest change is not simply a new reporting format. It is a push to make quality reporting match the way care is actually organized.
For healthcare providers, that can be good news. It can also create real operational pressure.
Benefits for healthcare providers
The shift to MVPs gives practices a chance to reduce reporting clutter and make performance work more useful. The benefits will not appear automatically. They depend on preparation, technology, and leadership. Still, the direction is promising.
Reporting can become easier to manage
A focused pathway can reduce the time spent sorting through a large measure inventory. Instead of starting each year with a broad search for reportable measures, practices can begin with the MVP that best fits their care model.
That can make training easier. It can also help quality teams explain reporting requirements to clinicians because the measures share a clinical theme.
This matters for smaller practices. Many do not have large compliance departments or dedicated analytics teams. A clearer structure can help them focus effort where it counts.
Measures can support better patient care
When measures relate to each other, they can reveal care gaps more clearly.
A practice managing patients with diabetes, for example, may already track lab results, blood pressure control, eye exams, kidney health, medication safety, and follow-up patterns. If the relevant pathway groups related measures, teams can use reporting data to identify patients who need outreach or care plan updates.
That turns MIPS data into a practical tool. It can help answer questions such as:
Which patients are overdue for follow-up?
Where are care transitions breaking down?
Are high-risk patients receiving consistent monitoring?
Do certain locations or teams need workflow support?
Are documentation gaps hiding care that already happened?
Better reporting does not guarantee better care. But better-aligned reporting can make quality work easier to connect to daily clinical decisions.
Performance feedback may become more meaningful
Traditional MIPS feedback can be difficult to interpret because reported measures vary widely. MVPs may make comparisons more useful by grouping similar clinicians and measure sets.
A practice can look at performance with more context. Instead of asking whether a random measure score improved, leaders can ask whether the pathway shows progress in a specific care area.
That can support more useful conversations among clinicians, quality staff, and administrators. It may also help practices decide where to invest, such as care management, patient reminders, EHR build changes, or referral tracking.
How practices can prepare before 2029
The best time to prepare is before the reporting requirement feels urgent. Practices that wait until the traditional MIPS sunset is close may face rushed decisions, technology gaps, and staff frustration.
Review available MVPs each year
CMS continues to add and revise MVPs. Practices should review the available pathways annually and identify which ones match their specialty mix, patient population, and existing measure performance.
A multi-specialty group may need more than one pathway. A small practice may have one obvious fit. Some clinicians may not yet see an ideal MVP for their work, which is one reason annual review matters.
When reviewing pathways, practices should ask:
Does this MVP reflect the care we provide most often?
Do we already capture the required data?
Which measures have reliable EHR support?
Which measures require workflow changes?
How would subgroup reporting affect our organization?
What performance risks appear in quality, cost, or Promoting Interoperability?
Map current MIPS measures to MVP measures
Many practices already report MIPS measures. The next step is to compare current measures with likely MVP requirements.
This mapping exercise can reveal three categories:
Measures already in place
These are the easiest to carry forward. The practice already knows the workflow, data source, and reporting process.
Measures that need workflow changes
These may require staff training, new documentation fields, patient outreach, or better follow-up tracking.
Measures that are not currently feasible
These need early attention. The barrier may be EHR configuration, missing data, specialty workflow, or lack of registry support.
This work should include clinicians, not just reporting staff. A measure that looks simple on paper may be difficult in the exam room. A clinician may also know where the data already exists but is not being captured in a reportable way.
Talk with EHR vendors and registries early
Technology will play a major role in MVP readiness. Practices should ask vendors and qualified registries direct questions:
Which MVPs do you support now?
Which MVPs are on your development roadmap?
Can we test measure performance before submission?
How are numerator and denominator logic displayed?
What data fields must clinicians complete?
How often can reports be refreshed?
Can performance be reviewed by clinician, location, or subgroup?
Do not wait until the reporting year begins to ask these questions. Reporting success often depends on build work completed months earlier.
Build a compact governance process
MVP readiness needs clear ownership. That does not require a large committee, but it does require a repeatable process.
A practical governance model includes:
A clinician lead who understands care delivery
A quality or compliance lead who tracks CMS requirements
An EHR or analytics lead who validates data
An operations lead who can change workflows
A finance lead who understands payment impact
The group should meet at set points during the year, especially before measure selection, during performance monitoring, and before submission.
Challenges practices may face
MVPs can make reporting better, but the transition will not be effortless. Several challenges are likely.
Not every specialty may have the right pathway right away
Some practices may find a clear fit. Others may feel that available MVPs only partly reflect their work. Specialty societies and professional groups may continue to push for new or improved pathways.
Until the measure set matures, some clinicians may need to choose the closest fit and watch for updates.
Data quality can become a bigger issue
A smaller measure set does not mean easier data validation. In fact, focused reporting may make documentation gaps more visible.
If a key field is missing, placed in free text, or captured outside the EHR, performance may look worse than the care provided. Practices need to check whether their data is structured, complete, and reportable.
This is especially true for care provided across settings. Referrals, outside test results, hospital follow-up, and patient-reported information can be hard to capture cleanly.
Cost performance can feel unclear
Cost measures can frustrate clinicians because they may not see the claims data until after the fact. MVPs may improve the connection between cost and clinical context, but practices still need education on what drives cost scores.
Teams should review feedback reports when available and look for patterns. Avoidable emergency department use, duplicative testing, delayed follow-up, and poor care transitions can all affect cost in some care models.
Change fatigue is real
Many practices are already managing prior authorization, staffing shortages, EHR burden, payer requirements, and patient access demands. A reporting transition can feel like one more task.
Leaders can reduce friction by keeping the message practical. MVP preparation should not be framed as abstract compliance. It should focus on fewer measures, cleaner workflows, better data, and clearer care priorities.
What the transition means for the next few years
The years before 2029 should be treated as a testing period. Practices do not need to solve everything at once, but they should begin moving toward MVP readiness now.
A sensible timeline might look like this:
Timeframe | Practical focus |
Now | Learn the MVP structure and identify likely pathways |
Next reporting cycle | Compare current MIPS measures with MVP options |
12 to 24 months out | Test reporting workflows and validate EHR data |
Before 2029 | Train teams, monitor performance, and finalize pathway strategy |
Practices that already participate in traditional MIPS have a foundation. The task is to reshape that foundation around more connected measure sets.
The most prepared organizations will likely be the ones that do three things well:
Choose pathways based on clinical fit, not convenience alone
Fix data capture problems before they affect payment
Use performance reports to improve care, not just complete submission
MIPS MVPs will not remove every reporting burden. They will not make value-based care simple overnight. But they do create a clearer direction for the program.
For healthcare providers, the significance is practical. Reporting is moving closer to specialty care, patient conditions, and measurable outcomes. That shift can support better care planning, clearer accountability, and less scattered reporting work.
The next step is to review current MIPS workflows and ask where they would fit inside an MVP. By 2029, that question will no longer be optional. Starting now gives practices the best chance to make the transition with less disruption and more value for patients.
Comments